Thymosin as a possible therapeutic drug for COVID-19: A case report

BACKGROUND: There are no effective antiviral therapies for coronavirus disease 2019 (COVID-19) at present. Although most patients with COVID-19 have a mild or moderate course of disease, up to 5%-10% of patients may have a serious and potentially life-threatening condition, indicating an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qiong Na, Xu, Mei Yan, Gan, Fang Min, Ye, Sha Sha, Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180217/
https://www.ncbi.nlm.nih.gov/pubmed/34141770
http://dx.doi.org/10.12998/wjcc.v9.i16.4090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180217/
https://www.ncbi.nlm.nih.gov/pubmed/34141770
http://dx.doi.org/10.12998/wjcc.v9.i16.4090

Ejemplares similares